The Children's Oncology Group Radiation Oncology Discipline: 15 Years of Contributions to the Treatment of Childhood Cancer
John C. Breneman(University of Cincinnati), John A. Kalapurakal(Northwestern University), Louis S. Constine(University of Rochester Medical Center), Jeff Buchsbaum(National Institutes of Health), Joseph Panoff(University of Miami), Arnold C. Paulino(The University of Texas MD Anderson Cancer Center), Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Thomas E. Merchant(St. Jude Children's Research Hospital), David Hodgson(The University of Texas MD Anderson Cancer Center), Paul J. Chuba(St. John Hospital & Medical Center), Kenneth Ulin(University of Massachusetts Chan Medical School), Torunn I. Yock(Massachusetts General Hospital), Sarah S. Donaldson(Stanford University), Karen J. Marcus(Harvard University), D Followill(The University of Texas MD Anderson Cancer Center), Arthur J. Olch(University of Southern California), Matt Krasin(St. Jude Children's Research Hospital), Anita Mahajan(Mayo Clinic in Arizona), Stephanie A. Terezakis(Johns Hopkins University), Nadia N. Laack(Mayo Clinic), Peter J. Houghton(The University of Texas at San Antonio Health Science Center), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Natia Esiashvili(Emory University), Daphne A. Haas‐Kogan(Brigham and Women's Hospital), Clayton B. Hess(Harvard University), Chia-Ho Hua(St. Jude Children's Research Hospital), Fran Laurie(University of Massachusetts Chan Medical School)
International Journal of Radiation Oncology*Biology*Physics
March 18, 2018
Cited by 47
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
|Neuro-Oncology|2013|942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806